Last reviewed · How we verify
NCT04447521: STREPTO
Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium
trial in Pneumonia in 3,600 participants. Status unknown.
1 May 2025
Quick facts
| Lead sponsor | Sciensano |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 3,600 |
| Start date | 1 September 2020 |
| Primary completion | 1 May 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Belgium |
Conditions studied
- Pneumonia — all drugs for Pneumonia →
- Otitis Media — all drugs for Otitis Media →
- Sinusitis Bacterial — all drugs for Sinusitis Bacterial →
Sponsor
Sciensano
Who can join
Eligibility, any sex, with Pneumonia or Otitis Media. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators will conduct a prospective observational study of non-invasive S. pneumoniae infections in Belgium and characterize serotype distributions to evaluate national vaccination programs.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Non-invasive <i>Streptococcus pneumoniae</i> infections are associated with different serotypes than invasive infections, Belgium, 2020 to 2023.
Passaris I, Depickère S, Braeye T, Mukovnikova M, et al · · 2024 · cited 7× · PMID 39512163 · DOI 10.2807/1560-7917.es.2024.29.45.2400108
Verify or expand the search:
- PubMed search for NCT04447521
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pneumonia
Currently open trials in the same condition.
- NCT07453966 — Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mec · NA · recruiting
- NCT07251465 — A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia · active not recruiting
- NCT07311343 — Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia · Phase 4 · recruiting
- NCT07298889 — High PEEP in Noninvasive Ventilation Patients With Pneumonia or ARDS · NA · recruiting
- NCT06911658 — Infectious Complications After Esophagectomy · recruiting
Other Sciensano trials
Trials by the same sponsor.
- NCT06007001 — Telerehabilitation and Tele-psychological Support in Cancer Patients eCAN JA · NA · recruiting
- NCT04852861 — COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine · Phase 4 · completed
- NCT04738695 — SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19) · completed
- NCT05373420 — COVID-19 Vaccination Uptake in Belgium : Sociodemographic and Socioeconomic Disparities · completed
- NCT04613817 — Sero-prevalence COVID-19 Among Belgian Children · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04447521 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sciensano
- Last refreshed: 27 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04447521.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing